Gliomas are incurable malignancies notable for having an immunosuppressive microenvironment with abundant myeloid cells, the…
karnottMarch 7, 2025
Explore Now
News and Articles
A vast search of natural diversity has led scientists at MIT’s McGovern Institute and the…
karnottMarch 7, 2025
Gensaic, Inc. (Gensaic), a biotechnology company that combines AI-powered protein design with biological insights to…
karnottMarch 6, 2025
Two papers published today in the journal Nature describe a significant advance in understanding the…
karnottMarch 6, 2025
Exhausted CD8+ T cells are key targets of immune checkpoint blockade therapy and their ineffective reinvigoration…
pthomsonDecember 10, 2021
Prognostically relevant RNA expression states exist in pancreatic ductal adenocarcinoma (PDAC), but our understanding of…
pthomsonDecember 8, 2021
Glucose metabolism modulates the islet β cell responses to diabetogenic stress, including inflammation. Here, we…
pthomsonDecember 3, 2021
Cancer progresses by evading the immune system. Elucidating diverse immune evasion strategies is a critical…
pthomsonDecember 2, 2021
Yevgeniy Semenov, MD, MA, a physician-investigator in the Mass General Department of Dermatology and an…
karnottJuly 29, 2024
There are many drugs that anesthesiologists can use to induce unconsciousness in patients. Exactly how…
karnottJuly 25, 2024
Whitehead Institute Member Siniša Hrvatin is studying tardigrades to decode the mechanisms enabling their survival…
karnottJuly 25, 2024
News and Articles
Five Harvard Medical School researchers are among the 150 newly elected members of the National…
karnottMay 12, 2025
A major contributor to poor sensitivity to anti-cancer kinase inhibitor therapy is drug-induced cellular adaptation,…
karnottMay 12, 2025
Moyamoya disease — a rare, progressive condition that narrows the brain’s blood vessels — leads…
karnottMay 9, 2025
Upcoming Events in Boston
Stay up-to-date with all of the life science events taking place in Boston with the Science in Boston events calendar!
